Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marta Palafox
Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs.
Molecular Cancer Therapeutics
Cancer Research
Oncology
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity Against Breast Cancer Models Resistant to Anti-Her2 Drugs
PLoS ONE
Multidisciplinary
Related publications
Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma
International Journal of Oncology
Cancer Research
Oncology
CDK4 Expression in Chordoma: A Potential Therapeutic Target Running Title: CDK4 Expression in Chordoma
Journal of Orthopaedic Research
Orthopedics
Sports Medicine
CDK4 as a Phytochemical Based Anticancer Drug Target
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
A Novel Tankyrase Inhibitor, MSC2504877, Enhances the Effects of Clinical CDK4/6 Inhibitors
Scientific Reports
Multidisciplinary
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
PLoS ONE
Multidisciplinary
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression
Molecular Cancer Therapeutics
Cancer Research
Oncology
Cdk4/6-Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Clinical Cancer Research
Cancer Research
Oncology
